产品说明书
Epelsiban
 |
同义名 : | GSK 557296 |
| CAS号 : | 872599-83-2 | |
| 货号 : | A762266 | |
| 分子式 : | C30H38N4O4 | |
| 纯度 : | 98% | |
| 分子量 : | 518.647 | |
| MDL号 : | MFCD26961099 | |
| 存储条件： |
粉末 液体 -20°C:3-6个月-80°C:12个月 |
|
| 溶解度 : | - | |
| 动物实验配方： |
| 生物活性 | |||
|---|---|---|---|
| 描述 | GSK 557296 is a potent, selective and orally bioavailable oxytocin receptor antagonist, with a pKi of 9.9 for human oxytocin receptor. | ||
| 临床研究 | |||||
|---|---|---|---|---|---|
| NCT号 | 适应症或疾病 | 临床期 | 招募状态 | 预计完成时间 | 地点 |
| NCT02794467 | Adenomyosis | Phase 2 | Withdrawn(Study was prematurel... 展开 >>y discontinued due to GSK's change in prioritization for the portfolio and is not due to any safety concerns or regulatory interaction.) 收起 << | October 2016 | United States, District of Col... 展开 >>umbia GSK Investigational Site Washington, DC, District of Columbia, United States, 20036 United States, Florida GSK Investigational Site West Palm Beach, Florida, United States, 33409 United States, Illinois GSK Investigational Site Champaign, Illinois, United States, 61820 United States, Louisiana GSK Investigational Site Mandeville, Louisiana, United States, 70471 GSK Investigational Site Metairie, Louisiana, United States, 70006 United States, Nebraska GSK Investigational Site Lincoln, Nebraska, United States, 68510 United States, Nevada GSK Investigational Site Las Vegas, Nevada, United States, 89128 United States, New Jersey GSK Investigational Site Lawrenceville, New Jersey, United States, 08648 United States, North Carolina GSK Investigational Site Durham, North Carolina, United States, 27713 GSK Investigational Site Raleigh, North Carolina, United States, 27612 United States, Ohio GSK Investigational Site Englewood, Ohio, United States, 45322 United States, Pennsylvania GSK Investigational Site Pittsburgh, Pennsylvania, United States, 15206 United States, Texas GSK Investigational Site Houston, Texas, United States, 77030 收起 << |
| NCT02257359 | Embryo Transfer | Phase 1 | Completed | - | United States, Kansas ... 展开 >> GSK Investigational Site Overland Park, Kansas, United States, 66211 收起 << |
| NCT02213029 | Embryo Transfer | Phase 1 | Terminated | - | United States, California ... 展开 >> GSK Investigational Site Glendale, California, United States, 91206 United States, Maryland GSK Investigational Site Baltimore, Maryland, United States, 21225 收起 << |
| 实验方案 | |||
|---|---|---|---|
| 1mg | 5mg | 10mg | |
|
1 mM 5 mM 10 mM |
1.93mL 0.39mL 0.19mL |
9.64mL 1.93mL 0.96mL |
19.28mL 3.86mL 1.93mL |
